Publication: Efficacy of mefenamic acid and hyoscine for pain relief during saline infusion sonohysterography in infertile women: A double blind randomized controlled trial
Issued Date
2011-04-01
Resource Type
ISSN
03012115
Other identifier(s)
2-s2.0-79952991391
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
European Journal of Obstetrics Gynecology and Reproductive Biology. Vol.155, No.2 (2011), 193-198
Suggested Citation
Rossathum Jareethum, Singpetch Suksompong, Somsin Petyim, Japarath Prechapanich, Pitak Laokirkkiat, Roungsin Choavaratana Efficacy of mefenamic acid and hyoscine for pain relief during saline infusion sonohysterography in infertile women: A double blind randomized controlled trial. European Journal of Obstetrics Gynecology and Reproductive Biology. Vol.155, No.2 (2011), 193-198. doi:10.1016/j.ejogrb.2010.11.021 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/12553
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Efficacy of mefenamic acid and hyoscine for pain relief during saline infusion sonohysterography in infertile women: A double blind randomized controlled trial
Other Contributor(s)
Abstract
Objectives: To evaluate the efficacy and level of satisfaction from mefenamic acid and hyoscine when used for pain relief during saline infusion sonohysterography. Study design: In this double blind randomized controlled trial, 141 nulliparous women were allocated to receive 500 mg of mefenamic acid, 10 mg of hyoscine or a placebo, which was packed in the same outer capsule. Saline infusion sonohysterography (SIS) was performed 30 min later by one operator. Pain and satisfaction scores were evaluated using a 10 cm visual analog scale. Baseline characteristics, pain and satisfaction scores were compared among the three groups. Pain scores were recorded before, after catheter insertion, during, immediately after, and 30 min after the procedure. Results: No statistically significant differences were found in baseline characteristics, pain and satisfaction scores among the three groups. Maximum pain during SIS was 4.40 ± 3.34, 4.67 ± 3.14 and 4.85 ± 3.19 in the mefenamic acid, hyoscine and placebo groups respectively. There was a 31.1% prevalence of intrauterine abnormality and the most frequent finding was endometrial polyp. Conclusion: There is no benefit in using mefenamic acid and hyoscine in the prevention of pain occurring from SIS. © 2010 Elsevier Ireland Ltd.